Viridian Therapeutics, Inc.\DE (VRDN) Cost of Revenue (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) reported Cost of Revenue of $692,000 for Q4 2016, up 51.8% from $456,000 a year earlier and up 15.5% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Cost of Revenue (2013 - 2016) Analysis & Trends
For FY2016, Viridian Therapeutics, Inc.\DE posted Cost of Revenue of $2.55 million, up 3.1% from FY2015.
- Cost of Revenue has a three-year compound annual growth rate of -2.8% (FY2013 to FY2016).
- By year, Cost of Revenue came in at $2.47 million in FY2015 (-26.6%), $3.37 million in FY2014 (+21.2%) and $2.78 million in FY2013.
- The Q4 2016 figure ranks as the highest quarterly Cost of Revenue since Q1 2015.
- Year over year, Cost of Revenue gained in three of the last eight quarters, with an average decline of 8.9%.
- The high point for year-over-year Cost of Revenue in five years was Q2 2014 (growth of 58.2%); the low point was Q4 2015 (a decline of 41.6%).
- Per Business Quant data, the three quarters before Q4 2016 came in at $599,000 (Q3 2016), $628,000 (Q2 2016) and $629,000 (Q1 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.53 Bn | -576.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 692,000.00 |
| Sep 30, 2016 | 599,000.00 |
| Jun 30, 2016 | 628,000.00 |
| Mar 31, 2016 | 629,000.00 |
| Dec 31, 2015 | 456,000.00 |
| Sep 30, 2015 | 577,000.00 |
| Jun 30, 2015 | 678,000.00 |
| Mar 31, 2015 | 760,000.00 |
| Dec 31, 2014 | 781,000.00 |
| Sep 30, 2014 | 900,000.00 |
| Jun 30, 2014 | 954,000.00 |
| Mar 31, 2014 | 731,000.00 |
| Dec 31, 2013 | 667,677.00 |
| Sep 30, 2013 | 713,200.00 |
| Jun 30, 2013 | 603,054.00 |
API Access
Viridian Therapeutics, Inc.\DE Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();